Preferential translation of reovirus mRNA by a σ3-dependent mechanism

Virology

Volumn 232, Issue 1, 1997, Pages 62-73

  Schmechel, Stephen ^a   Chute, Michael ^a   Skinner, Pamela ^a   Anderson, Robert ^a   Schiff, Leslie ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; GENE EXPRESSION REGULATION; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; REOVIRUS; RNA ANALYSIS; RNA TRANSLATION; VIRAL GENETICS;

EID: 0030921401     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8531     Document Type: Article

References (45)

1. Beattie E., Denzler K. L., Tartaglia J., Perkus M. E., Paoletti E., Jacobs B. L. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:1995;499-505.
2. Brendler T., Godefroy-Colburn T., Carlill R. D., Thach R. E. The role of mRNA competition in regulating translation. II. Development of a quantitative in vitro assay. J. Biol. Chem. 256:1981;11747-11754.
3. Brown T. Analysis of RNA by northern and slot blot hybridization. Current Protocols in Molecular Biology. 1993;Wiley, New York. p. 4.9.1-4.9.14.
4. Cervera M., Dreyfuss G., Penman S. Messenger RNA is translated when associated with the cytoskeletal framework in normal and VSV-infected HeLa cells. Cell. 23:1981;113-120.
5. Danis C., Lemay G. Protein synthesis in different cell lines infected with orthoreovirus serotype 3: inhibition of host-cell protein synthesis correlates with accelerated viral multiplication and cell killing. Biochem. Cell Biol. 71:1993;81-85.
6. Denzler K. L., Jacobs B. L. Site-directed mutagenic analysis of reovirus sigma 3 protein binding to dsRNA. Virology. 204:1994;190-199.
7. Detjen B. M., Walden W. E., Thach R. E. Translational specificity in reovirus-infected mouse fibroblasts. J. Biol. Chem. 257:1982;9855-9860.
8. Dryden K. A., Wang G., Yeager M., Nibert M. L., Coombs K. M., Furlong D. B., Fields B. N., Baker T. S. Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: Analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction. J. Cell Biol. 122:1993;1023-1041.
9. Feduchi E., Esteban M., Carrasco L. Reovirus type 3 synthesizes proteins in interferon-treated HeLa cells without reversing the antiviral state. Virology. 164:1988;420-426.
10. Furlong D. B., Nibert M. L., Fields B. N. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J. Virol. 62:1988;246-256.
11. Giantini M., Shatkin A. J. Stimulation of chloramphenicol acetyltransferase mRNA translation by reovirus capsid polypeptide sigma 3 in cotransfected COS cells. J. Virol. 63:1989;2415-2421.
12. Hesketh J. E., Pryme I. F. Interaction between mRNA, ribosomes, and the cytoskeleton. Biochem. J. 277:1991;1-10.
13. Hovanessian A. G. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2′,5′-oligoadenylate synthetases. J. Interferon Res. 11:1991;199-205.
14. Huismans H., Joklik W. K. Reovirus-coded polypeptides in infected cells: isolation of two native monomeric polypeptides with affinity for single-stranded and double-stranded RNA, respectively. Virology. 70:1976;411-424.
15. Imani F., Jacobs B. L. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc. Natl. Acad. Sci. USA. 85:1988;7887-7891.
16. Jeffrey I. W., Kadereit S., Meurs E. F., Metzger T., Bachmann M., Schwemmle M., Hovanessian A. G., Clemens M. J. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp. Cell Res. 218:1995;17-27.
17. Jimenez-Gardia L. F., Green S. R., Matthews M. B., Spector D. L. Organization of the double-stranded RNA-activated protein kinase DAI and virus-associated VA RNAI in adenovirus-2-infected HeLa cells. J. Cell Sci. 106:1993;11-22.
18. Katze M. G., Lara J., Wambach M. Nontranslated cellular mRNAs are associated with the cytoskeletal framework in influenza virus or adenovirus infected cells. Virology. 169:1989;312-322.
19. Kedl R., Schmechel S., Schiff L. Comparative sequence analysis of the reovirus S4 genes from 13 serotype 1 and serotype 3 field isolates. J. Virol. 69:1995;552-559.
20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
21. Lemieux R., Beaud G. Expression of vaccinia virus early mRNA in Ehrlich ascites tumor cells. 2. Part of the polysomes at an early stage of virus infection are not bound to the cytoskeleton. Eur. J. Biochem. 129:1982;273-279.
22. Lemieux R., Zarbl H., Millward S. Messenger RNA discrimination in extracts from uninfected and reovirus infected L cells. J. Virol. 51:1984;215-222.
23. Lloyd R. M., Shatkin A. J. Translational stimulation by reovirus polypeptide sigma 3: substitution for VAI RNA and inhibition of phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66:1992;6878-6884.
24. Lu Y., Wambach M., Katze M. G., Krug R. M. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology. 214:1995;222-228.
25. Marie I., Svab J., Robert N., Galabru J., Hovanessian A. G. Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J. Biol. Chem. 265:1990;18601-18607.
26. Meurs E. F., Watanabe Y., Kadereit S., Barber G. N., Katze M. G., Chong K., Williams B. R. G., Hovanessian A. G. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66:1992;5805-5814.
27. Miller J. E., Samuel C. E. Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: Identification of a repeated basic amino acid motif within the C-terminal binding region. J. Virol. 66:1992;5347-5356.
28. Munemitsu S. M., Samuel C. E. Biosynthesis of reovirus-specified polypeptides. Multiplication rate but not yield of reovirus serotypes 1 and 3 correlates with the level of virus-mediated inhibition of cellular protein synthesis. Virology. 136:1984;133-143.
29. Quinlan M. P., Chen L. B., Knipe D. M. The intranuclear location of a herpes simplex virus DNA binding protein is determined by the status of viral DNA replication. Cell. 36:1984;857-868.
30. Ray B. K., Brendler T. G., Adya S., Daniels-McQueen S., Miller J. K., Hershey J. W., Grifo J. A., Merrick W. C., Thach R. E. Role of mRNA competition in regulating translation: further characterization of mRNA discriminatory initiation factors. Proc. Natl. Acad. Sci. USA. 80:1983;663-667.
31. Samuel C. E. Antiviral actions of interferon: Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 183:1991;1-11.
32. Schiff L. A., Nibert M. L., Co M. S., Brown E. G., Fields B. N. Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein sigma 3. Mol. Cell. Biol. 8:1988;273-283.
33. Sharpe A. H., Chen L. B., Fields B. N. The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells. Virology. 120:1982;399-411.
34. Sharpe A. H., Fields B. N. Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene. Virology. 122:1982;381-391.
35. Skup D., Millward S. mRNA capping enzymes are masked in reovirus progeny subviral particles. J. Virol. 34:1980a;490-496.
36. Skup D., Millward S. Reovirus-induced modification of cap-dependent translation in infected L cells. Proc. Natl. Acad. Sci. USA. 77:1980b;152-156.
37. Tillotson L., Shatkin A. J. Reovirus polypeptide sigma 3 and N-terminal myristoylation of polypeptide mu 1 are required for site-specific cleavage to mu 1C in transfected cells. J. Virol. 66:1992;2180-2186.
38. Tyler K. L., Bronson R. T., Byers K. B., Fields B. Molecular basis of viral neurotropism: experimental reovirus infection. Neurology. 35:1985;88-92.
39. Virgin H. W., Mann M. A., Fields B. N., Tyler K. L. Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J. Virol. 65:1991;6772-6781.
40. Walden W. E., Godefroy-Colburn T., Thach R. E. The role of mRNA competition in regulating translation. I. Demonstration of competition in vivo. J. Biol. Chem. 256:1981;11739-11746.
41. Xiao Q., Sharp T. V., Jeffrey I. W., James M. C., Pruijn G. J., van Venrooij W. J., Clemens M. J. The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Res. 22:1994;2512-2518.
42. Yue Z., Shatkin A. J. Regulated, stable expression and nuclear presence of reovirus double-stranded RNA-binding protein s3 in HeLa cells. J. Virol. 70:1996;3497-3501.
43. Yuwen H., Cox J. H., Yewdell J. W., Bennink J. R., Moss B. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology. 195:1993;732-744.
44. Zarbl H., Skup D., Millward S. Reovirus progeny subviral particles synthesize uncapped mRNA. J. Virol. 34:1980;497-505.
45. Zweerink H. J., Joklik W. K. Studies on the intracellular synthesis of reovirus-specified proteins. Virology. 41:1970;501-518.